Delcath's Q4 sales exceeded expectations due to HEPZATO KIT adoption. Discover insights into its profitability, CHOPIN trial ...

Pembrolizumab shows clinical promise as a treatment for mycosis fungoides and Sézary syndrome, achieving a response in nearly ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

Compass Therapeutics has announced top-line data from its ongoing COMPANION-002 trial investigating its antibody-based ...

An international team of researchers, including experts from the University of Adelaide, has found genomic testing and ...

The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin combined with doxorubicin, ...

Basal Cell Carcinoma CSR Highlights <li /> CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two pati ...

Given GTA 6's promise of cutting-edge technology, the game could take inspiration from Red Dead Redemption 2's conditions ...

During a live event, Payal D. Shah, MD, discusses the case of a woman with metastatic breast cancer and the data for ...

An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.